Total Payments
$8,162
2024 Payments
$220.69
Companies
21
Transactions
79
Medicare Patients
1,385
Medicare Billing
$267,431
Payment Breakdown by Category
Consulting$3,850 (47.2%)
Travel$2,053 (25.1%)
Food & Beverage$1,992 (24.4%)
Education$267.42 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,850 | 1 | 47.2% |
| Travel and Lodging | $2,053 | 10 | 25.1% |
| Food and Beverage | $1,992 | 62 | 24.4% |
| Education | $267.42 | 6 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $5,261 | 15 | $0 (2019) |
| Clovis Oncology, Inc. | $1,423 | 20 | $0 (2019) |
| Amgen Inc. | $254.60 | 9 | $0 (2019) |
| Merck Sharp & Dohme LLC | $163.38 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $156.89 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $124.11 | 1 | $0 (2024) |
| Celgene Corporation | $121.34 | 1 | $0 (2017) |
| Pacira Pharmaceuticals Incorporated | $120.52 | 1 | $0 (2017) |
| Lupin Inc. | $101.88 | 1 | $0 (2019) |
| Shionogi Inc | $97.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.69 | 3 | GlaxoSmithKline, LLC. ($124.11) |
| 2019 | $474.09 | 17 | Clovis Oncology, Inc. ($129.82) |
| 2018 | $6,626 | 37 | TESARO, Inc. ($5,159) |
| 2017 | $841.48 | 22 | Celgene Corporation ($121.34) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 03/18/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $72.58 | General |
| 09/05/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Oncology | ||||||
| 08/19/2019 | Covidien LP | TruClear (Device) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Hysteroscopy Systems | ||||||
| 08/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2019 | Amgen Inc. | MVASI (Biological), Neulasta | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Oncology | ||||||
| 07/29/2019 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, DURAGEN | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEURO CRITICAL CARE | ||||||
| 07/16/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Oncology | ||||||
| 07/11/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
| 06/11/2019 | Amgen Inc. | Neulasta (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 05/08/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $2.55 | General |
| Category: Oncology | ||||||
| 04/18/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Oncology | ||||||
| 04/11/2019 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $101.88 | General |
| Category: OBSTETRICSGYNECOLOGY | ||||||
| 04/04/2019 | Amgen Inc. | — | Education | In-kind items and services | $59.99 | General |
| 04/03/2019 | Amgen Inc. | Neulasta (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Oncology | ||||||
| 03/06/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Oncology | ||||||
| 02/20/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2018 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2018 | Amgen Inc. | Neulasta (Biological), NEUPOGEN | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 10/11/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Oncology | ||||||
| 09/20/2018 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/19/2018 | Kyowa Kirin, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: ANTIEMETIC - 5HT3 INHIBITOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 194 | 263 | $84,576 | $24,113 |
| 2022 | 6 | 209 | 273 | $95,446 | $27,816 |
| 2021 | 14 | 311 | 1,465 | $122,852 | $38,750 |
| 2020 | 24 | 671 | 20,955 | $580,346 | $176,752 |
Total Patients
1,385
Total Services
22,956
Medicare Billing
$267,431
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 12 | 12 | $27,511 | $8,361 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 127 | $22,225 | $5,788 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 66 | $16,500 | $4,826 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $10,080 | $3,012 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 19 | $6,460 | $1,792 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,800 | $333.00 | 18.5% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 15 | 15 | $34,276 | $10,897 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 113 | $19,550 | $5,162 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 74 | $18,500 | $4,789 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $14,280 | $4,632 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 20 | $6,800 | $1,922 | 28.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 17 | $2,040 | $413.83 | 20.3% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 12 | 12 | $27,511 | $8,638 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 96 | $22,278 | $7,799 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 133 | $19,530 | $6,857 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 31 | $8,868 | $3,537 | 39.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 33 | $8,910 | $3,533 | 39.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $7,776 | $2,791 | 35.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,457 | $1,866 | 34.2% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 14 | 99 | $8,415 | $1,248 | 14.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 13 | 311 | $7,775 | $648.03 | 8.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 20 | $2,112 | $592.54 | 28.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 21 | $1,680 | $585.09 | 34.8% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2021 | 14 | 21 | $1,260 | $292.33 | 23.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 12 | $960.00 | $291.74 | 30.4% |
About Dr. Mary Cunningham, MD
Dr. Mary Cunningham, MD is a Gynecologic Oncology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902902760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Cunningham, MD has received a total of $8,162 in payments from pharmaceutical and medical device companies, with $220.69 received in 2024. These payments were reported across 79 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($3,850).
As a Medicare-enrolled provider, Cunningham has provided services to 1,385 Medicare beneficiaries, totaling 22,956 services with total Medicare billing of $267,431. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Syracuse, NY
- Active Since 09/16/2006
- Last Updated 01/13/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1902902760
Products in Payments
- ZEJULA (Drug) $5,261
- Rubraca (Drug) $1,423
- LYNPARZA (Drug) $156.89
- JEMPERLI (Biological) $124.11
- Otezla (Drug) $121.34
- EXPAREL (Drug) $120.52
- SOLOSEC (Drug) $101.88
- Neulasta (Biological) $100.24
- Osphena (Drug) $97.50
- Myrbetriq (Drug) $97.20
- KEYTRUDA (Biological) $49.71
- SANCUSO (Drug) $46.79
- NS Advanced (Device) $40.83
- PICO (Device) $40.44
- Avastin (Biological) $29.73
- MVASI (Biological) $19.38
- LYNPARZA (Biological) $17.09
- CODMAN CERTAS (Device) $16.97
- FLEXITOUCH (Device) $14.87
- YONDELIS (Drug) $13.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.